Validation of the artificial intelligence software to detect chronic fibrosing interstitial lung diseases in chest X-ray
H. Nishikiori (Sapporo, Japan), K. Hirota (Sapporo, Japan), T. Suzuki (Tokyo, Japan), Y. Takagi (Tokyo, Japan), S. Honda (Tokyo, Japan), K. Ikeda (Sapporo, Japan), Y. Mori (Sapporo, Japan), Y. Asai (Sapporo, Japan), N. Yama (Sapporo, Japan), H. Ohnishi (Sapporo, Japan), M. Hatakenaka (Sapporo, Japan), H. Chiba (Sapporo, Japan)
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Session: The future of idiopathic pulmonary fibrosis
Session type: Oral Presentation
Number: 1211
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Nishikiori (Sapporo, Japan), K. Hirota (Sapporo, Japan), T. Suzuki (Tokyo, Japan), Y. Takagi (Tokyo, Japan), S. Honda (Tokyo, Japan), K. Ikeda (Sapporo, Japan), Y. Mori (Sapporo, Japan), Y. Asai (Sapporo, Japan), N. Yama (Sapporo, Japan), H. Ohnishi (Sapporo, Japan), M. Hatakenaka (Sapporo, Japan), H. Chiba (Sapporo, Japan). Validation of the artificial intelligence software to detect chronic fibrosing interstitial lung diseases in chest X-ray. 1211
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: